Aidapak Recalls Pregabalin Capsules Due to Potential Label Mixup
Aidapak Services, LLC is recalling Pregabalin 200 mg capsules because they may have been mislabeled as other prescription drugs.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, but the source text explicitly states no illnesses or injuries have been reported, and the hazard is a labeling error rather than a high-risk pathogen or structural defect, fitting the 'Moderate' criteria for minor labeling errors or low-risk contamination.
Plain-English summary
Aidapak Services, LLC is voluntarily recalling 540-capsule bottles of Pregabalin, 200 mg, capsules (NDC 00071101768). The recall was initiated because the product may have been mislabeled as other prescription medications, including Losartan Potassium, Cyanocobalamin, and Clonazepam.
The repacked drugs were distributed in Arizona, California, Oregon, and Washington. The source text does not specify the total number of units affected or report any illnesses or injuries associated with the mislabeling.
Consumers should check their medication labels and contact their pharmacist or healthcare provider if they have received Pregabalin 200 mg capsules that may be mislabeled. The recall is classified as FDA Class II, indicating a situation where use of, or exposure to, the product may cause temporary or medically reversible health consequences.
The recalled product
- Product
- PREGABALIN, Capsule, 200 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00071101768.
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 540
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (14)
- Labeling: Label Mixup: PREGABALIN
- Capsule
- 200 mg has the following codes: Pedigree: AD21787_1
- EXP: 5/1/2014
- Pedigree: AD30024_1
- EXP: 5/9/2014
- Pedigree: AD73518_4
- EXP: 5/31/2014
- Pedigree W002759
- EXP: 6/6/2014
- Pedigree: W003397
- EXP: 6/19/2014
- Pedigree: W003398
- EXP: 6/19/2014.
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- HighJ K Patisserie Chocolate Chip Cookies Recalled for Undeclared Soy
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateAidapak Recalls Trimethobenzamide Capsules Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Phosphorus Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Phytonadione Tablets Due to Potential Labeling Mixup
FDA (Drugs) · 2014-01-22
- SevereAidapak Recalls Clomipramine Capsules Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-22
- SevereAidapak Recalls OXcarbazepine Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Caffeine Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-22